Philips connected device improves medication adherence
Royal Philips announced new study results demonstrating the use of a connected medication dispensing technology can greatly benefit patients with chronic conditions, helping them...
Philips partners with Heart Hospital Tampere to collaborate on a Finnish center of excellence...
Multi-year strategic partnership agreement to install and manage integrated imaging and informatics solutions to make cardiac care at Heart Hospital’s new site and existing...
Point-of-care ultrasound indispensable for elite sport in Wales
Point-of-care ultrasound is an essential tool for Dr Mark Ridgewell, an early pioneer for sports and exercise medicine (SEM) and, for the past 13...
FDA Expands Indication of INVOKAMET (canagliflozin/metformin HCl) to Include First-Line Treatment of
Janssen Pharmaceuticals, Inc. announced the U.S. FDA has approved INVOKAMET, a fixed-dose combination therapy of INVOKANA® (canagliflozin) and metformin hydrochloride, for first-line treatment of...
3M Announces Interactive Compendium on the Science and Clinical Benefits of Patient Warming
3M, a world leader in infection prevention, announced the publication of a robust research compendium highlighting the safety and effectiveness of the 3M™ Bair...
European Medicines Agency accepted Sandozs biosimilar rituximab regulatory submission
Sandoz advances biosimilar portfolio with sixth major biosimilar file acceptance in less than one yearSandoz is seeking approval for all indications included in the...
Varian Medical Systems Announces Plan To Spin Off Imaging Components Business
Imaging Components business will become a new independent publicly traded company, which will be spun off by means of a tax-free distribution to Varian...
Novartis’ Entresto given strong Class I recommendation in both US and EU heart failure...
US guidelines now recommend Entresto as standard of care for HFrEF as an alternative to ACEs or ARBs; call for doctors to switch...
Novartis starts FortiHFy clinical program to study heart failure
Fortifying Heart Failure clinical evidence and patient quality of life (FortiHFy) is an umbrella clinical program comprising over 40 active or planned trialsÂ
...
GE Healthcare and Accenture Target $2 Billion in Lost Revenue Among US Healthcare Providers
GE Healthcare and Accenture introduced a new offering to help improve medical claims processing and related cash flow for healthcare providers. The alliance, targeting...
